Fractyl Health, headquartered in Burlington, Massachusetts, focuses on treating metabolic diseases like type 2 diabetes and obesity with its Revita DMR System and Rejuva gene therapy. The company went public on February 2, 2024, and employs 102 full-time staff.
William Bradley bought 16,129 shares of GUTS on 13 March at $1.26 per share, worth a total of $20K. They now own 16,129 GUTS shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.